HDFC Life Insurance Company Share Price

HDFC Life Insur.

CMP as on 22-Jan-21 15:55

₹ 687.40
-13.10 -1.87%

Open

₹ 702.70

Turnover (lac)

₹ 18,177

Prev. Close

₹ 700.50

Day's Vol (shares)

₹ 26,44,349

Day's Range (₹)

₹ 684.10
₹ 708.80

CMP as on22-Jan-21 15:59

₹ 687.65
-13 -1.86%

Open

₹ 702.50

Turnover (lac)

₹ 731

Prev. Close

₹ 700.65

Day's Vol (shares)

₹ 1,69,948

Day's Range

₹ 684.25
₹ 708.30

CMP as on 22-Jan-21 0:00

₹ 688.00
-12.9 -1.84%

Open

₹ 702.00

Open Interest(Contracts)

₹ 66,02,200

VWAP

₹ 694.95

Day's Vol (shares)

₹ 33,96,800

Day's Range (Ex.Dt. 28 Jan 2021)

₹ 685.25
₹ 708.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 31-Dec-2020 - -
HDFC Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2021 ,inter alia, to consider and approve the audited standalone financial results and un-audited consolidated financial results of the Company for the quarter and nine-month ended December 31, 2020. Please find enclosed outcome of the Board Meeting held on January 22, 2021. (As Per BSE Announcement dated on 22.01.2021)
Board Meeting - 12-Oct-2020 - -
HDFC Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2020 ,inter alia, to consider and approve the audited standalone financial results and un-audited consolidated financial results for the quarter and half year ended September 30, 2020. Please find enclosed outcome of the Board Meeting held on October 19, 2020. (As Per BSE Announcement Dated on 19.10.2020)
Board Meeting - 30-Jun-2020 - -
HDFC Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2020 ,inter alia, to consider and approve the audited standalone financial results and un-audited consolidated financial results for the quarter ended June 30, 2020. Window for trading in the equity shares of the Company shall remain closed from July 1, 2020 up to July 23, 2020 (both days inclusive) for all the Designated Persons including their Immediate Relatives and Promoters of the Company, etc. in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Companys Code of Conduct for Prevention of Insider Trading. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board of Directors of the Company at their meeting held today i.e. July 21, 2020, have approved the Audited Standalone and Un-audited Consolidated financial results for the quarter ended June 30, 2020. In this regard, please find enclosed herewith the following:- (i) Copy of Audited Standalone financial results along with auditors report (ii) Copy of Un-audited Consolidated financial results with limited review report (iii) Note on Impact of COVID-19 (iv) Press Release. (As Per BSE Announcement Dated 21.07.2020)
Board Meeting - 22-Apr-2020 - -
HDFC Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2020 ,inter alia, to consider and approve 1) the audited standalone and consolidated financial results for the quarter and year ended March 31, 2020 2) To consider raising of funds by way of issuance of Non-Convertible Debentures in the nature of subordinated debt as per IRDAI (Other Forms of Capital) Regulations, 2015 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. April 27, 2020 have approved the following :- 1) Financial Results and 2) In principle approval for raising of funds by issuance of Non-Convertible Debentures (NCDs) (As Per BSE Announcement Dated on 27.04.2020) Inter alia, approved the following: 1. In principle approval for raising of funds by issuance of Non-Convertible Debentures (NCDs) Raising of funds through issuance of NCDs in the nature of Subordinated debt instrument up to Rs. 600 Crore (Rupees Six Hundred Crore only) in one or more tranches, on private placement basis subject to receipt of all the Regulatory approvals. The Company has taken cognizance of IRDAI Circular No. IRDA/F&A/CIR/MISC/099/04/2020 dated April 24, 2020, urging the Insurers to take conscious call to refrain from dividend pay-outs from profits pertaining to financial year ending March 31, 2020. (As Per BSE Bulletin Dated on 27.04.2020)